Tinea Versicolor Treatment Cream

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Tinea Versicolor Treatment Cream
Generic name: CLOTRIMAZOLE
Manufacturer: Beautivity LLC
Product type: HUMAN OTC DRUG
SPL set ID: 32d71d7e-3c78-6b63-e063-6294a90adaed
SPL ID: 5566ae2e-a723-421a-e063-6394a90ac026
Version: 3
Effective date: 2026-06-29
Source export date: 2026-09-28
Source partition: 4
Source file: https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/c7ca0b7091cdaeab3f27713a6eef00adcf8fe722383633ddce61531b4c840544/drug-label-0004-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:26:26

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M005	openfda.application_number
brand name		Tinea Versicolor Treatment Cream	openfda.brand_name
generic name		CLOTRIMAZOLE	openfda.generic_name
manufacturer name		Beautivity LLC	openfda.manufacturer_name
ndc	package	85398-002-01	openfda.package_ndc
ndc	product	85398-002	openfda.product_ndc
ndc11	package	85398000201	derived:openfda.package_ndc
rxcui		309367	openfda.rxcui
spl id		5566ae2e-a723-421a-e063-6394a90ac026	id
spl set id		32d71d7e-3c78-6b63-e063-6294a90adaed	set_id
unii		G07GZ97H65	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For External Use Only it on children under 2 years of age unless directed by a doctor. avoid contact with eyes, if contact occurs, rinse the eyes very thoroughly with water. Stop Using and Ask a Physician if irritation occurs or there is no improvement within 4 weeks. keep out of the reach of young children.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.